Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Zenith Epigenetics reports novel bromodomain inhibitors

Feb. 18, 2015

Roche develops neurogenesis-stimulating naphthyridines

Feb. 18, 2015

Nanjing Sanhome Pharmaceutical patents ABL inhibitors

Feb. 18, 2015

Polish and French team discloses 5-HT6 receptor antagonists

Feb. 17, 2015

Janssen discloses new anti-HBV compounds

Feb. 17, 2015

Actelion patents CXCR3 receptor antagonists

Feb. 17, 2015

Bayer divulges dual BRD4/PLK1 inhibitors

Feb. 17, 2015

New Bcl-2 inhibitors disclosed by Servier and Vernalis

Feb. 17, 2015

Scientists at Instituto Italiano di Tecnologia disclose FAAH inhibitors

Feb. 16, 2015

New FXIa inhibitors designed by Bayer

Feb. 16, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...